Allergy Immunotherapy
Allergy Immunotherapy Market by Treatment Type (Epicutaneous Immunotherapy, Oral Immunotherapy, Subcutaneous Immunotherapy), Allergen Type (Animal Dander, Dust Mites, Food Allergens), Immunotherapy Delivery Form, Technology Platform, Allergy Type, End User, Distribution Channel - Global Forecast 2025-2030
SKU
MRR-436901065A53
Region
Global
Publication Date
February 2025
Delivery
Immediate
2024
USD 1.86 billion
2025
USD 2.04 billion
2030
USD 3.30 billion
CAGR
10.03%

The Allergy Immunotherapy Market size was estimated at USD 1.86 billion in 2024 and expected to reach USD 2.04 billion in 2025, at a CAGR 10.03% to reach USD 3.30 billion by 2030.

Allergy Immunotherapy Market
To learn more about this report, request a free PDF copy

Allergy immunotherapy, often known as desensitization or hypo-sensitization, involves the administration of increasing doses of allergens to patients, aiming to modify the immune system's response to allergens. The necessity for this therapy lies in its potential to provide long-term relief and modify the natural course of allergic diseases, differing from standard symptomatic treatments. Its applications are broad, targeting allergic rhinitis, asthma, and insect sting allergies, with subcutaneous and sublingual routes being predominant. The end-use scope encompasses hospitals, clinics, and home healthcare setups. Key growth influencers include the rising prevalence of allergies worldwide, advancements in immunotherapy technology, and increased awareness among healthcare professionals and patients. The continuous research and development are unlocking potential opportunities, such as improved allergen extracts, personalized immunotherapy, and combination therapies enhancing efficacy and safety. However, growth is challenged by factors like high costs, limited awareness in emerging regions, stringent regulatory requirements, and potential side effects causing hesitancy among patients. The market also faces competition from conventional and alternative treatments. Innovations can emerge from research on more effective delivery systems, like nanoparticle formulations providing targeted delivery, and genetic research opening pathways for personalized allergy treatments. Additionally, AI-driven models hold promise for predicting patient responses and optimizing treatment regimens. For businesses, tapping into digital health platforms for patient engagement and monitoring can offer significant growth. Companies are recommended to focus on partnerships with research institutions to advance technology and on educational campaigns to enhance awareness and drive adoption. Despite challenges, the nature of the market is dynamic, with a steady demand fueled by the increasing burden of allergic conditions and a patient population seeking more sustainable solutions.

Ask ResearchAI anything

World's First Innovative Al for Market Research

Ask your question about the Allergy Immunotherapy market, and ResearchAI will deliver precise answers.
How ResearchAI Enhances the Value of Your Research
ResearchAI-as-a-Service
Gain reliable, real-time access to a responsible AI platform tailored to meet all your research requirements.
24/7/365 Accessibility
Receive quick answers anytime, anywhere, so you’re always informed.
Maximize Research Value
Gain credits to improve your findings, complemented by comprehensive post-sales support.
Multi Language Support
Use the platform in your preferred language for a more comfortable experience.
Stay Competitive
Use AI insights to boost decision-making and join the research revolution at no extra cost.
Time and Effort Savings
Simplify your research process by reducing the waiting time for analyst interactions in traditional methods.

Market Dynamics

The market dynamics represent an ever-changing landscape of the Allergy Immunotherapy Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Growing prevalence of allergic conditions raises demand for allergy immunotherapy solutions
    • Government initiatives and favorable healthcare policies supporting the integration of immunotherapy
    • Increasing awareness and diagnosis of allergies contributes to the demand for innovative treatments
  • Market Restraints
    • High cost of developing allergy immunotherapy limits accessibility for patients and healthcare systems
  • Market Opportunities
    • Developing allergy immunotherapy solutions addressing cross-reactive allergens prevalent in multiple regions
    • Expansion potential of digital platforms for remote consultations and telehealth allergy care services
  • Market Challenges
    • Stringent regulatory frameworks and lengthy approval processes for new product launches

Market Segmentation Analysis

  • Treatment Type: Rising need for sublingual immunotherapy for treating pollen and dust mite allergies

    Epicutaneous immunotherapy (EPIT) involves administering allergens via a patch on the skin, offering a less invasive option that is particularly advantageous for children and those averse to injections. It shows promise, particularly in treating peanut and milk allergies, with ongoing studies to assess its long-term efficacy and safety. Oral immunotherapy (OIT) requires patients to consume controlled, gradually increasing amounts of allergens. It has gained traction for food allergy treatments, especially for peanuts, with studies indicating significant success in increasing threshold doses that trigger allergic reactions.

    Subcutaneous immunotherapy (SCIT), often called allergy shots, is the traditional and most established form of immunotherapy. SCIT is widely used for respiratory allergies, delivering allergens via injections over several years, contributing to long-term symptom remission. Sublingual immunotherapy (SLIT) is gaining popularity as a needle-free alternative where allergens are placed under the tongue. SLIT is particularly effective for treating pollen and dust mite allergies. While it offers convenience and safety, its efficacy for broader allergens is still being explored.

  • End User: Growing significance of allergy immunotherapy in hospitals to manage chronic allergies

    Homecare settings have seen a rise in demand as patients seek convenient treatment options and personalized care. The availability of advanced sublingual immunotherapy products facilitates at-home administration, thereby reducing the need for frequent clinical visits and enhancing patient compliance. Hospitals serve as primary centers for allergy immunotherapy, offering comprehensive care with access to specialized medical professionals and advanced diagnostic tools. They often cater to severe cases requiring close monitoring and complex treatment regimens, thus playing a crucial role in managing chronic allergies.

    Research & academic laboratories are pivotal in advancing immunotherapy through innovative research and clinical trials. They contribute to developing novel therapies and personalized medicine approaches, thereby expanding the understanding and effectiveness of allergy treatments. Specialty clinics focus on delivering targeted allergy testing and treatment, offering tailored care plans that cater to individual patient needs. These clinics often provide a range of immunotherapy options, including subcutaneous and sublingual therapies, benefitting patients with easier access to specialized expertise and personalized follow-up care.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Allergy Immunotherapy Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

PESTLE Analysis

The PESTLE analysis offers a comprehensive tool for understanding and analyzing the external macro-environmental factors that impact businesses within the Allergy Immunotherapy Market. This framework examines Political, Economic, Social, Technological, Legal, and Environmental factors, providing companies with insights into how these elements influence their operations and strategic decisions. By using PESTLE analysis, businesses can identify potential opportunities and threats in the market, adapt to changes in the external environment, and make informed decisions that align with current and future conditions. This analysis helps companies anticipate shifts in regulation, consumer behavior, technology, and economic conditions, allowing them to better navigate risks and capitalize on emerging trends.

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Allergy Immunotherapy Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Allergy Immunotherapy Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Recent Developments

  • Stallergenes Greer strengthens Nordic presence with new affiliate for allergen immunotherapy

    Stallergenes Greer, a leading global company in allergen immunotherapy, is expanding its operations into the Nordic region with the creation of an affiliate, Stallergenes Greer Danmark ApS. The expansion emphasizes Stallergenes Greer's commitment to enhancing quality of life for allergy patients and increasing its footprint in comprehensive allergy care services [Published On: October 24, 2024]

  • Australia initiates groundbreaking peanut allergy treatment program for infants

    Australia introduced a world-first nationwide program offering life-saving treatment for infants with severe peanut allergies. The initiative involves giving eligible babies daily doses of peanut powder over two years to enhance their immune tolerance to peanuts, supervised by healthcare professionals at ten pediatric hospitals. [Published On: July 31, 2024]

  • FDA approves Xolair to mitigate allergic reactions from multiple food allergens

    The FDA approved Xolair (omalizumab) for reducing allergic reactions, including anaphylaxis, in individuals with IgE-mediated food allergies, making it the first medication capable of addressing multiple food allergens. Intended for repeated use, Xolair is not a substitute for emergency treatment and requires continuous avoidance of allergens. [Published On: February 16, 2024]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Allergy Immunotherapy Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Allergy Immunotherapy Market, highlighting leading vendors and their innovative profiles. These include Adamis Pharmaceuticals Corporation, ALK-Abelló, Inc., Allergy Therapeutics PLC, Anergis SA, ASIT Biotech by DMS Imaging, ASIT Biotech SA, Biomay AG, Biomunex Pharmaceuticals SAS, BioSpace, Inc., Circassia Group PLC, DBV Technologies SA, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, HAL Allergy B.V., HollisterStier Allergy by Jubilant Pharma Company, Jubilant HollisterStier LLC, LETI Pharma, S.L.U., Merck KGaA, Mylan N.V. by Viatris Inc., NOVARTIS AG, Sanofi S.A, Stallergenes Greer International AG, Stallergenes Greer Ltd, and Torii Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Allergy Immunotherapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Treatment Type
    • Epicutaneous Immunotherapy
    • Oral Immunotherapy
    • Subcutaneous Immunotherapy
    • Sublingual Immunotherapy
  • Allergen Type
    • Animal Dander
      • Cat Allergens
      • Dog Allergens
    • Dust Mites
    • Food Allergens
      • Egg Allergens
      • Milk Allergens
      • Peanut Allergens
      • Tree Nut Allergens
    • Pollen
  • Immunotherapy Delivery Form
    • Dermal Patch
    • Drops
    • Injections
    • Tablets
  • Technology Platform
    • Adjuvants
    • Nanotechnology-Based Platforms
    • Recombinant Allergens
  • Allergy Type
    • Allergic Asthma
    • Allergic Rhinitis
    • Atopic Dermatitis
    • Urticaria
  • End User
    • Homecare Settings
    • Hospitals
    • Research & Academic Laboratories
    • Specialty Clinics
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

This research report offers invaluable insights into various crucial aspects of the Allergy Immunotherapy Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Allergy Immunotherapy Market, by Treatment Type
  7. Allergy Immunotherapy Market, by Allergen Type
  8. Allergy Immunotherapy Market, by Immunotherapy Delivery Form
  9. Allergy Immunotherapy Market, by Technology Platform
  10. Allergy Immunotherapy Market, by Allergy Type
  11. Allergy Immunotherapy Market, by End User
  12. Allergy Immunotherapy Market, by Distribution Channel
  13. Americas Allergy Immunotherapy Market
  14. Asia-Pacific Allergy Immunotherapy Market
  15. Europe, Middle East & Africa Allergy Immunotherapy Market
  16. Competitive Landscape
  17. List of Figures [Total: 31]
  18. List of Tables [Total: 422 ]
  19. List of Companies Mentioned [Total: 25]
360iResearch Analyst Ketan Rohom
Download a Free PDF
Get a sneak peek into the valuable insights and in-depth analysis featured in our comprehensive allergy immunotherapy market report. Download now to stay ahead in the industry! Need more tailored information? Ketan is here to help you find exactly what you need.
Frequently Asked Questions
  1. How big is the Allergy Immunotherapy Market?
    Ans. The Global Allergy Immunotherapy Market size was estimated at USD 1.86 billion in 2024 and expected to reach USD 2.04 billion in 2025.
  2. What is the Allergy Immunotherapy Market growth?
    Ans. The Global Allergy Immunotherapy Market to grow USD 3.30 billion by 2030, at a CAGR of 10.03%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.